Cryo Cell International (CCEL) Total Non-Current Liabilities (2010 - 2026)
Cryo Cell International (CCEL) posted quarterly Total Non-Current Liabilities of $15.9 million for Q2 2026, down 26.77% year-over-year from $21.8 million in Q2 2025, and down 10.32% quarter-over-quarter from $17.8 million in Q1 2026.
Cryo Cell International (CCEL) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Cryo Cell International (CCEL) has reported Total Non-Current Liabilities for 17 consecutive years, with $15.9 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Total Non-Current Liabilities fell 26.77% year-over-year to $15.9 million; the TTM figure through May 2026 stood at $15.9 million (down 26.77% YoY), while the FY2025 annual figure was $80.3 million, up 271.71% from the prior year.
- Total Non-Current Liabilities eased to $15.9 million in Q2 2026 per CCEL's latest filing, from $17.8 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $80.3 million in Q4 2025 and bottomed at $15.7 million in Q2 2022.
- Historically, Total Non-Current Liabilities has averaged $39.0 million across 5 years, with a median of $21.7 million in 2024.
- On a YoY basis, Total Non-Current Liabilities climbed as much as 341.66% in 2023 and fell as far as 72.77% in 2023.
- Cryo Cell International's Total Non-Current Liabilities stood at $19.5 million in 2022, then advanced by 7.1% to $20.9 million in 2023, then grew by 3.53% to $21.6 million in 2024, then jumped by 271.71% to $80.3 million in 2025, then tumbled by 80.16% to $15.9 million in 2026.
- Business Quant data shows CCEL's Total Non-Current Liabilities at $15.9 million in Q2 2026, $17.8 million in Q1 2026, and $80.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn | 60.86 Bn |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn | 20.20 Bn |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn | 3.78 Bn |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn | 16.53 Bn |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn | 3.11 Bn |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn | 15.38 Bn |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn | 4.30 Bn |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn | 735.40 Mn |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn | 2.46 Bn |
| 10 | Cryo Cell International | 32.09 Mn | 28.93 Mn | 6.10 Mn | 15.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 15.93 Mn |
| Feb 28, 2026 | 17.76 Mn |
| Nov 30, 2025 | 80.29 Mn |
| Aug 31, 2025 | 77.95 Mn |
| May 31, 2025 | 21.75 Mn |
| Feb 28, 2025 | 21.72 Mn |
| Nov 30, 2024 | 21.60 Mn |
| Aug 31, 2024 | 72.45 Mn |
| May 31, 2024 | 19.45 Mn |
| Feb 29, 2024 | 72.01 Mn |
| Nov 30, 2023 | 20.86 Mn |
| Aug 31, 2023 | 18.56 Mn |
| May 31, 2023 | 69.39 Mn |
| Feb 28, 2023 | 18.91 Mn |
| Nov 30, 2022 | 19.48 Mn |
| Aug 31, 2022 | 68.16 Mn |
| May 31, 2022 | 15.71 Mn |
| Feb 28, 2022 | 49.98 Mn |
| Nov 30, 2021 | 21.07 Mn |
| Aug 31, 2021 | 19.86 Mn |